Hostname: page-component-7bb8b95d7b-s9k8s Total loading time: 0 Render date: 2024-09-07T14:05:16.776Z Has data issue: false hasContentIssue false
  • English
  • Français

Noradrenaline and Tardive Dyskinesia

Published online by Cambridge University Press:  29 January 2018

R. Sandyk  and
M. A. Gillman
R. Sandyk
Affiliation:
South African Brain Research Institute, Johannesburg 2000, South Africa
M. A. Gillman
Affiliation:
South African Brain Research Institute, Johannesburg 2000, South Africa
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 145 , Issue 2 , August 1984 , pp. 217
Copyright
Copyright © Royal College of Psychiatrists, 1984 

References

Hornykiewicz, O. (1982) Brain catecholamines in schizophrenia a good case for nor-adrenalin. Nature, 299, 484–6.CrossRefGoogle Scholar
Korsgaard, S. (1976) Baclofen (Liorasal) in the treatment of neuroleptic-induced tardive dyskenesia. Acta Psychiatrica Scandinavica, 54, 17–22.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.